What is the current annual free cash flow of GSK?

As of today, GSK annual free cash flow is $5.69B

What is 1-year change in GSK annual free cash flow?

GSK annual free cash flow is up +43.24% year-over-year

What is 3-year change in GSK annual free cash flow?

GSK annual free cash flow is up +5.79% over the past 3 years

How far is GSK annual free cash flow from its all-time high?

GSK annual free cash flow is currently -34.74% below its historical high of $8.72B set on December 31, 2008

How does GSK annual free cash flow rank versus sector peers?

GSK annual free cash flow is higher than 98.49% of companies in Healthcare sector

When is GSK next annual earnings release?

The next annual earnings release for GSK is on February 3, 2027

What is the current quarterly free cash flow of GSK?

As of today, GSK quarterly free cash flow is $3.05B

What is GSK quarterly free cash flow most recent change?

GSK quarterly free cash flow was up +21.63% on September 30, 2026

What is 1-year change in GSK quarterly free cash flow?

GSK quarterly free cash flow is up +67.17% year-over-year

How far is GSK quarterly free cash flow from its all-time high?

GSK quarterly free cash flow is currently -28.49% below its historical high of $4.27B set on December 31, 2018

How does GSK quarterly free cash flow rank versus sector peers?

GSK quarterly free cash flow is higher than 98.65% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on February 3, 2027

What is the current TTM free cash flow of GSK?

As of today, GSK TTM free cash flow is $7.85B

What is GSK TTM free cash flow most recent change?

GSK TTM free cash flow was up +18.54% on September 30, 2026

What is 1-year change in GSK TTM free cash flow?

GSK TTM free cash flow is up +39.01% year-over-year

How far is GSK TTM free cash flow from its all-time high?

GSK TTM free cash flow is currently -21.91% below its historical high of $10.05B set on June 30, 2010

How does GSK TTM free cash flow rank versus sector peers?

GSK TTM free cash flow is higher than 98.84% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on February 3, 2027

GSK Plc (GSK) Free Cash Flow History & Chart Since 1991

Annual FCF

$5.69B$1.72B+43.24%

December 31, 2025

Summary

Current Value: As of today, GSK annual free cash flow is $5.69B, up +43.24% on December 31, 2025
Historical Performance: GSK annual free cash flow is up +5.79% over the past 3 years, down -17.94% over the past 5 years
All-Time High Comparison: GSK annual free cash flow is currently -34.74% below its historical high of $8.72B set on December 31, 2008
3-Year Low Comparison: GSK annual free cash flow is +43.24% above its 3-year low of $3.97B reached on December 31, 2024
Sector Comparison: GSK annual free cash flow is higher than 98.49% of companies in Healthcare sector

Free Cash Flow Chart

beforeafter

Performance

GSK Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Free Cash Flow	Dec 31, 25	$5.69B	+43.2%	+5.8%	-17.9%	-18.3%
Quarterly Free Cash Flow	Sep 30, 26	$3.05B	+67.2%	+42.8%	+66.0%	+24.0%
TTM Free Cash Flow	Sep 30, 26	$7.85B	+39.0%	+148.0%	+36.0%	+34.1%
Price	Nov 6, 26	$50.33	+6.9%	+44.7%	+13.5%	+11.1%
Annual Cash From Operations	Dec 31, 25	$9.62B	+23.7%	+17.9%	-1.9%	+1.4%
Annual CAPEX	Dec 31, 25	$3.93B	+3.2%	+41.4%	+37.0%	+55.9%
Annual Dividends Paid	Dec 31, 25	$3.38B	+8.2%	-20.9%	-33.7%	-31.7%
Annual Net Income	Dec 31, 25	$8.29B	+119.8%	+36.7%	+1.2%	+189.8%
Annual Revenue	Dec 31, 25	$43.05B	+7.4%	+19.2%	-1.5%	-1.8%

Free Cash Flow Highs

GSK Annual Free Cash Flow Highs Comparison
Period	High	Date	Current
3Y	$5.69B	Dec 31, 25	at high
5Y	$6.93B	N/A	-17.9%
All	$8.72B	Dec 31, 08	-34.7%

Free Cash Flow Lows

GSK Annual Free Cash Flow Lows Comparison
Period	Low	Date	Current
3Y	$3.97B	Dec 31, 24	+43.2%
5Y	$3.97B	Dec 31, 24	+43.2%
All	$15.28M	Dec 31, 15	>+9999.0%

Free Cash Flow History

Year	Value	Change
2025	$5.69B	+43.2%
2024	$3.97B	-20.2%
2023	$4.98B	-7.5%
2022	$5.38B	-14.0%
2021	$6.26B	-9.8%
2020	$6.93B	+7.6%
2019	$6.44B	-19.1%
2018	$7.96B	+54.3%
2017	$5.16B	+8.8%
2016	$4.74B	>+9,900.0%
2015	$15.28M	-99.7%
2014	$4.59B	-39.6%
2013	$7.59B	+122.7%
2012	$3.41B	-50.2%
2011	$6.85B	-1.6%
2010	$6.96B	-16.2%
2009	$8.31B	-4.7%
2008	$8.72B	+11.8%

Year	Value	Change
2007	$7.80B	+58.9%
2006	$4.91B	-42.5%
2005	$8.53B	+24.8%
2004	$6.84B	+7.5%
2003	$6.36B	-0.6%
2002	$6.40B	+30.1%
2001	$4.92B	+11.1%
2000	$4.43B	+17.7%
1999	$3.76B	+89.4%
1998	$1.99B	-14.3%
1997	$2.32B	-0.1%
1996	$2.32B	-29.7%
1995	$3.30B	+108.7%
1994	$1.58B	+14.2%
1993	$1.39B	+51.4%
1992	$915.75M	+61.7%
1991	$566.21M	-

FAQ

What is the current annual free cash flow of GSK?: As of today, GSK annual free cash flow is $5.69B
What is 1-year change in GSK annual free cash flow?: GSK annual free cash flow is up +43.24% year-over-year
What is 3-year change in GSK annual free cash flow?: GSK annual free cash flow is up +5.79% over the past 3 years
How far is GSK annual free cash flow from its all-time high?: GSK annual free cash flow is currently -34.74% below its historical high of $8.72B set on December 31, 2008
How does GSK annual free cash flow rank versus sector peers?: GSK annual free cash flow is higher than 98.49% of companies in Healthcare sector
When is GSK next annual earnings release?: The next annual earnings release for GSK is on February 3, 2027

Free Cash Flow Formula

FCF = CFO − CAPEX

Quarterly FCF

$3.05B$543.15M+21.63%

September 30, 2026

Summary

Current Value: As of today, GSK quarterly free cash flow is $3.05B, up +21.63% on September 30, 2026
Historical Performance: GSK quarterly free cash flow is up +67.17% year-over-year, up +42.82% over the past 3 years
All-Time High Comparison: GSK quarterly free cash flow is currently -28.49% below its historical high of $4.27B set on December 31, 2018
3-Year Low Comparison: GSK quarterly free cash flow is +540.67% above its 3-year low of $476.75M reached on March 31, 2024
Sector Comparison: GSK quarterly free cash flow is higher than 98.65% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Free Cash Flow	Sep 30, 26	$3.05B	+21.6%	+67.2%	+42.8%	+66.0%
Annual Free Cash Flow	Dec 31, 25	$5.69B	–	+43.2%	+5.8%	-17.9%
TTM Free Cash Flow	Sep 30, 26	$7.85B	+18.5%	+39.0%	+148.0%	+36.0%
Price	Nov 6, 26	$50.33	-3.5%	+6.9%	+44.7%	+13.5%
Quarterly Cash From Operations	Sep 30, 26	$3.77B	+11.5%	+24.5%	+35.8%	+7.7%
Quarterly CAPEX	Sep 30, 26	$719.73M	-17.7%	-40.2%	+12.2%	-56.8%
Quarterly Dividends Paid	Sep 30, 26	$920.84M	-5.3%	+1.5%	+26.2%	-30.1%
Quarterly Net Income	Sep 30, 26	$2.29B	+208.4%	-20.8%	+17.9%	+75.6%
Quarterly Revenue	Sep 30, 26	$11.94B	+5.8%	+3.6%	+15.8%	+30.8%

Quarterly Free Cash Flow Highs

GSK Quarterly Free Cash Flow Highs Comparison
Period	High	Date	Current
1Y	$3.05B	Sep 30, 26	at high
3Y	$3.05B	Sep 30, 26	at high
5Y	$3.99B	Dec 31, 21	-23.4%
All	$4.27B	Dec 31, 18	-28.5%

Quarterly Free Cash Flow Lows

GSK Quarterly Free Cash Flow Lows Comparison
Period	Low	Date	Current
1Y	$886.58M	Mar 31, 26	+244.5%
3Y	$476.75M	Mar 31, 24	+540.7%
5Y	-$527.33M	Mar 31, 23	+679.2%
All	-$4.40B	Dec 31, 00	+169.4%

Quarterly Free Cash Flow History

Month	Value	Change
Sep 2026	$3.05B	+21.6%
Jun 2026	$2.51B	+183.2%
Mar 2026	$886.58M	-36.5%
Dec 2025	$1.40B	-23.6%
Sep 2025	$1.83B	+12.0%
Jun 2025	$1.63B	+90.3%
Mar 2025	$857.59M	-35.5%
Dec 2024	$1.33B	-19.5%
Sep 2024	$1.65B	+197.8%
Jun 2024	$554.48M	+16.3%
Mar 2024	$476.75M	-82.2%
Dec 2023	$2.68B	+25.1%
Sep 2023	$2.14B	+221.2%
Jun 2023	$665.87M	+226.3%
Mar 2023	-$527.33M	-159.5%
Dec 2022	$886.96M	+0.1%
Sep 2022	$886.05M	-12.7%
Jun 2022	$1.01B	-60.1%
Mar 2022	$2.55B	-36.1%
Dec 2021	$3.99B	+116.7%
Sep 2021	$1.84B	+220.9%
Jun 2021	$573.38M	+478.0%
Mar 2021	-$151.68M	-104.3%
Dec 2020	$3.51B	+1,490.2%
Sep 2020	$220.67M	-91.1%
Jun 2020	$2.49B	+249.7%
Mar 2020	$711.67M	-75.7%
Dec 2019	$2.93B	+15.2%
Sep 2019	$2.54B	+347.8%
Jun 2019	$567.66M	+64.5%
Mar 2019	$345.12M	-91.9%
Dec 2018	$4.27B	+106.1%
Sep 2018	$2.07B	+103.3%
Jun 2018	$1.02B	+56.9%
Mar 2018	$649.87M	-72.7%
Dec 2017	$2.38B	+33.7%
Sep 2017	$1.78B	+1,003.2%
Jun 2017	$161.50M	-80.2%
Mar 2017	$816.59M	-67.6%
Dec 2016	$2.52B	+47.0%
Sep 2016	$1.71B	+122.1%
Jun 2016	$771.03M	+395.8%
Mar 2016	-$260.63M	-132.2%
Dec 2015	$808.48M	+2,294.3%
Sep 2015	-$36.85M	+94.7%
Jun 2015	-$692.85M	-992.0%
Mar 2015	-$63.45M	-102.9%
Dec 2014	$2.21B	+68.4%
Sep 2014	$1.31B	+415.7%
Jun 2014	$254.04M	-69.7%
Mar 2014	$839.39M	-64.2%
Dec 2013	$2.34B	+0.1%
Sep 2013	$2.34B	+53.6%
Jun 2013	$1.52B	+10.0%

Month	Value	Change
Mar 2013	$1.38B	-16.9%
Dec 2012	$1.67B	+246.8%
Sep 2012	-$1.14B	-163.4%
Jun 2012	$1.79B	+63.9%
Mar 2012	$1.09B	-49.2%
Dec 2011	$2.15B	-12.7%
Sep 2011	$2.46B	+111.0%
Jun 2011	$1.17B	+5.9%
Mar 2011	$1.10B	-1.6%
Dec 2010	$1.12B	+25.6%
Sep 2010	$892.25M	-61.5%
Jun 2010	$2.32B	-21.0%
Mar 2010	$2.93B	+46.7%
Dec 2009	$2.00B	-28.6%
Sep 2009	$2.80B	+62.7%
Jun 2009	$1.72B	-17.6%
Mar 2009	$2.09B	+43.5%
Dec 2008	$1.45B	-46.4%
Sep 2008	$2.71B	+55.6%
Jun 2008	$1.74B	-45.0%
Mar 2008	$3.17B	+110.3%
Dec 2007	$1.51B	-46.0%
Sep 2007	$2.79B	+54.0%
Jun 2007	$1.81B	+5.3%
Mar 2007	$1.72B	-3.6%
Dec 2006	$1.79B	+358.5%
Sep 2006	-$691.40M	-146.1%
Jun 2006	$1.50B	-44.3%
Mar 2006	$2.69B	+61.6%
Dec 2005	$1.67B	-41.2%
Sep 2005	$2.83B	+16.4%
Jun 2005	$2.43B	+13.5%
Mar 2005	$2.14B	+96.0%
Dec 2004	$1.09B	-56.0%
Sep 2004	$2.48B	+24.6%
Jun 2004	$1.99B	+19.6%
Mar 2004	$1.67B	+47.2%
Dec 2003	$1.13B	-57.7%
Sep 2003	$2.67B	+100.2%
Jun 2003	$1.33B	-9.6%
Mar 2003	$1.48B	+24.9%
Dec 2002	$1.18B	-44.6%
Sep 2002	$2.13B	+6.3%
Jun 2002	$2.01B	+47.2%
Mar 2002	$1.36B	-10.0%
Dec 2001	$1.52B	+5.9%
Sep 2001	$1.43B	-14.0%
Jun 2001	$1.66B	+189.7%
Mar 2001	$574.60M	+113.1%
Dec 2000	-$4.40B	-219.7%
Sep 2000	$3.68B	+979.9%
Jun 2000	$340.38M	-77.6%
Mar 2000	$1.52B	-

FAQ

What is the current quarterly free cash flow of GSK?: As of today, GSK quarterly free cash flow is $3.05B
What is GSK quarterly free cash flow most recent change?: GSK quarterly free cash flow was up +21.63% on September 30, 2026
What is 1-year change in GSK quarterly free cash flow?: GSK quarterly free cash flow is up +67.17% year-over-year
How far is GSK quarterly free cash flow from its all-time high?: GSK quarterly free cash flow is currently -28.49% below its historical high of $4.27B set on December 31, 2018
How does GSK quarterly free cash flow rank versus sector peers?: GSK quarterly free cash flow is higher than 98.65% of companies in Healthcare sector
When is GSK next earnings release?: The next earnings release for GSK is on February 3, 2027

Free Cash Flow Formula

FCF = CFO − CAPEX

TTM FCF

$7.85B$1.23B+18.54%

September 30, 2026

Summary

Current Value: As of today, GSK TTM free cash flow is $7.85B, up +18.54% on September 30, 2026
Historical Performance: GSK TTM free cash flow is up +39.01% year-over-year, up +148.03% over the past 3 years
All-Time High Comparison: GSK TTM free cash flow is currently -21.91% below its historical high of $10.05B set on June 30, 2010
3-Year Low Comparison: GSK TTM free cash flow is +148.03% above its 3-year low of $3.16B reached on an earlier date
Sector Comparison: GSK TTM free cash flow is higher than 98.84% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM Free Cash Flow	Sep 30, 26	$7.85B	+18.5%	+39.0%	+148.0%	+36.0%
Annual Free Cash Flow	Dec 31, 25	$5.69B	–	+43.2%	+5.8%	-17.9%
Quarterly Free Cash Flow	Sep 30, 26	$3.05B	+21.6%	+67.2%	+42.8%	+66.0%
Price	Nov 6, 26	$50.33	-3.5%	+6.9%	+44.7%	+13.5%
TTM Cash From Operations	Sep 30, 26	$11.39B	+7.0%	+16.8%	+90.3%	+16.0%
TTM CAPEX	Sep 30, 26	$3.54B	-12.0%	-13.8%	+25.5%	-12.5%
TTM Dividends Paid	Sep 30, 26	$3.61B	+0.4%	+6.9%	+28.7%	-34.7%
TTM Net Income	Sep 30, 26	$6.48B	-8.5%	-18.7%	-19.2%	+9.3%
TTM Revenue	Sep 30, 26	$44.97B	+0.9%	+6.9%	+23.6%	+15.1%

TTM Free Cash Flow Highs

GSK TTM Free Cash Flow Highs Comparison
Period	High	Date	Current
1Y	$7.85B	Sep 30, 26	at high
3Y	$7.85B	Sep 30, 26	at high
5Y	$9.39B	Jun 30, 22	-16.4%
All	$10.05B	Jun 30, 10	-21.9%

TTM Free Cash Flow Lows

GSK TTM Free Cash Flow Lows Comparison
Period	Low	Date	Current
1Y	$5.65B	N/A	+39.0%
3Y	$3.16B	N/A	+148.0%
5Y	$1.91B	Jun 30, 23	+310.6%
All	-$729.27M	Sep 30, 01	+1176.1%

TTM Free Cash Flow History

Month	Value	Change
Sep 2026	$7.85B	+18.5%
Jun 2026	$6.62B	+15.3%
Mar 2026	$5.74B	+0.5%
Dec 2025	$5.71B	+1.2%
Sep 2025	$5.65B	+3.2%
Jun 2025	$5.47B	+24.5%
Mar 2025	$4.39B	+9.5%
Dec 2024	$4.01B	-25.1%
Sep 2024	$5.36B	-8.3%
Jun 2024	$5.85B	-1.9%
Mar 2024	$5.96B	+20.3%
Dec 2023	$4.95B	+56.5%
Sep 2023	$3.16B	+65.5%
Jun 2023	$1.91B	-15.4%
Mar 2023	$2.26B	-57.6%
Dec 2022	$5.33B	-36.8%
Sep 2022	$8.43B	-10.2%
Jun 2022	$9.39B	+4.9%
Mar 2022	$8.94B	+43.2%
Dec 2021	$6.25B	+8.3%
Sep 2021	$5.77B	+39.0%
Jun 2021	$4.15B	-31.6%
Mar 2021	$6.07B	-12.5%
Dec 2020	$6.93B	+9.1%
Sep 2020	$6.35B	-26.8%
Jun 2020	$8.67B	+28.5%
Mar 2020	$6.75B	+5.7%
Dec 2019	$6.38B	-17.4%
Sep 2019	$7.73B	+6.5%
Jun 2019	$7.26B	-5.9%
Mar 2019	$7.71B	-3.8%
Dec 2018	$8.01B	+30.8%
Sep 2018	$6.13B	+5.0%
Jun 2018	$5.83B	+17.2%
Mar 2018	$4.98B	-3.2%
Dec 2017	$5.14B	-2.6%
Sep 2017	$5.28B	+1.3%
Jun 2017	$5.21B	-10.5%
Mar 2017	$5.82B	+22.7%
Dec 2016	$4.74B	+56.4%
Sep 2016	$3.03B	+136.5%
Jun 2016	$1.28B	+805.0%
Mar 2016	-$181.84M	-1,285.3%
Dec 2015	$15.34M	-98.9%
Sep 2015	$1.41B	-48.8%
Jun 2015	$2.76B	-25.5%
Mar 2015	$3.71B	-19.6%
Dec 2014	$4.61B	-2.9%
Sep 2014	$4.75B	-17.8%
Jun 2014	$5.78B	-18.0%
Mar 2014	$7.05B	-7.2%
Dec 2013	$7.59B	+9.8%
Sep 2013	$6.92B	+101.1%
Jun 2013	$3.44B	-7.2%

Month	Value	Change
Mar 2013	$3.71B	+8.6%
Dec 2012	$3.41B	-12.4%
Sep 2012	$3.90B	-48.0%
Jun 2012	$7.50B	+9.1%
Mar 2012	$6.87B	-0.2%
Dec 2011	$6.88B	+17.6%
Sep 2011	$5.85B	+36.7%
Jun 2011	$4.28B	-21.2%
Mar 2011	$5.43B	-25.2%
Dec 2010	$7.27B	-10.8%
Sep 2010	$8.14B	-19.0%
Jun 2010	$10.05B	+6.3%
Mar 2010	$9.45B	+9.8%
Dec 2009	$8.60B	+6.8%
Sep 2009	$8.06B	+1.1%
Jun 2009	$7.97B	-0.3%
Mar 2009	$8.00B	-11.9%
Dec 2008	$9.08B	-0.6%
Sep 2008	$9.13B	-0.8%
Jun 2008	$9.21B	-0.7%
Mar 2008	$9.28B	+18.5%
Dec 2007	$7.83B	-3.4%
Sep 2007	$8.11B	+75.2%
Jun 2007	$4.63B	+7.3%
Mar 2007	$4.32B	-18.3%
Dec 2006	$5.28B	+2.4%
Sep 2006	$5.16B	-40.5%
Jun 2006	$8.68B	-9.7%
Mar 2006	$9.62B	+6.0%
Dec 2005	$9.07B	+6.7%
Sep 2005	$8.50B	+4.3%
Jun 2005	$8.15B	+5.7%
Mar 2005	$7.71B	+6.6%
Dec 2004	$7.23B	-0.5%
Sep 2004	$7.27B	-2.5%
Jun 2004	$7.46B	+9.7%
Mar 2004	$6.80B	+2.9%
Dec 2003	$6.61B	-0.8%
Sep 2003	$6.66B	+8.8%
Jun 2003	$6.13B	-9.9%
Mar 2003	$6.80B	+1.7%
Dec 2002	$6.69B	-4.8%
Sep 2002	$7.03B	+11.1%
Jun 2002	$6.32B	+5.8%
Mar 2002	$5.98B	+15.2%
Dec 2001	$5.19B	+811.6%
Sep 2001	-$729.27M	-148.2%
Jun 2001	$1.51B	+699.3%
Mar 2001	$189.40M	-83.3%
Dec 2000	$1.14B	-79.5%
Sep 2000	$5.54B	+197.5%
Jun 2000	$1.86B	+22.4%
Mar 2000	$1.52B	-

FAQ

What is the current TTM free cash flow of GSK?: As of today, GSK TTM free cash flow is $7.85B
What is GSK TTM free cash flow most recent change?: GSK TTM free cash flow was up +18.54% on September 30, 2026
What is 1-year change in GSK TTM free cash flow?: GSK TTM free cash flow is up +39.01% year-over-year
How far is GSK TTM free cash flow from its all-time high?: GSK TTM free cash flow is currently -21.91% below its historical high of $10.05B set on June 30, 2010
How does GSK TTM free cash flow rank versus sector peers?: GSK TTM free cash flow is higher than 98.84% of companies in Healthcare sector
When is GSK next earnings release?: The next earnings release for GSK is on February 3, 2027

Free Cash Flow Formula

FCF = CFO − CAPEX

Data Sources & References

GSK Official Website www.gsk.com
GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk